MedTrace Logo

Communicating a Cancer Diagnosis-Current Methods and Their Effects

NCT00674804 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1100

Last updated 2017-07-02

No results posted yet for this study

Summary

This study will investigate how patients are informed of their cancer diagnosis or recurrence and will explore their experience in learning about the diagnosis. Specifically, it will:

* Distinguish methods of telling the diagnosis and identify its relationship to the type of cancer.
* Determine if the way a patient is informed of their diagnosis is associated with their level of satisfaction with the method of being informed.
* Identify who informs the patient of their diagnosis..
* Determine patient satisfaction with their diagnostic consult.
* Identify indicators of satisfaction with the diagnostic consultation.

Patients 18 years of age or older who are enrolled in or being screened for enrollment in a phase I, II or III clinical trial in the National Cancer Institute's Medical Oncology, Metabolism, Surgery or Neuro-Oncology branch may be eligible for this study.

Participants complete a 15-minute questionnaire that includes questions related to the how they were informed of their cancer diagnosis.

Conditions

Sponsors & Collaborators

  • National Institutes of Health Clinical Center (CC)

    lead NIH

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-24
Primary Completion
2009-07-16
Completion
2009-07-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00674804 on ClinicalTrials.gov